Robert T. Jensen

New and emerging somatostatin therapies for neuroendocrine tumors: “what is in the pipeline”

INTRODUCTION: Somatostatin receptors (SSTRs) have played a central role in all aspects of the management of neuroendocrine/endocrine neoplasms (NENs). This includes in diagnosis of NENs with the widespread use of radiolabeled SSTR ligands to localize both the primary tumor locati...